Only 5 matching reports were clearly identified as United States-based, so broader patient experiences were included and are labeled as additional context. PulseGLP analyzed 90 relevance-ranked patient reports across GLP-1, Mounjaro, Zepbound from r/GLP1, r/Mounjaro, r/Zepbound. The strongest structured pattern in this sample is symptom: Other, appearing in 13 extracted reports. The matching posts skew Risk-Alert, Neutral-Low, Analytical. This is a matched-sample finding, not a population-wide prevalence estimate.
Share of structured matched reports; this is not a population prevalence estimate.
"CVS is adding Zepbound back to its formulary effective October 1 Huge news for those who lost coverage."
Patient · GLP-1 · r/GLP1 · United States
"Kwikpens are pretty new in the US, so not sure how much feedback you’ll get on that part. But in my experience, Walgreens is terrible when it comes to GLP-1’s."
Patient · Zepbound · r/Zepbound · United States
"Best pharm for Zepbound? Since January, I’ve had GLP-1 tirz delivered to my house via FedEx. On July 1st, however, I will be switching to Zepbound Kwikpen to take advantage of the $50/month offer for the next 1."
Patient · Zepbound · r/Zepbound · United States
"grey market reta risks range from bacterial contamination to underdosed or mislabeled vials, not just rashes but potential infections from impure compouds."
Patient · Retatrutide · r/Retatrutide · United States
Sourced from GLP-1 patient communities · See community discussion →
Published: · Updated: